Loading…
Dynamics of Serological and Mucosal Antibody Responses against African Swine Fever Viruses in Experimentally Infected Pigs
African swine fever virus (ASFV) is a lethal swine pathogen, and there is no effective vaccine or treatment available for ASFV infection. Recently, the occurrence of ASFV genotype I and genotype II natural mutants that manifest as subacute, longer-incubation, or persistent infections poses threats t...
Saved in:
Published in: | Transboundary and emerging diseases 2023-02, Vol.2023, p.1-12 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c337t-41367a6a5ec4d83789eba8fdad0308b91f5294aefb6e6484a1531f1de851667a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c337t-41367a6a5ec4d83789eba8fdad0308b91f5294aefb6e6484a1531f1de851667a3 |
container_end_page | 12 |
container_issue | |
container_start_page | 1 |
container_title | Transboundary and emerging diseases |
container_volume | 2023 |
creator | Xie, Qingyun Bai, Yun Wang, Wan Chen, Rong Xing, Huixuan Wu, Yuzi Shao, Guoqing Bu, Zhigao Zhao, Dongming Feng, Zhixin |
description | African swine fever virus (ASFV) is a lethal swine pathogen, and there is no effective vaccine or treatment available for ASFV infection. Recently, the occurrence of ASFV genotype I and genotype II natural mutants that manifest as subacute, longer-incubation, or persistent infections poses threats to preventing ASFV infection. The dynamics of antibody responses to ASFV are still completely unrevealed, especially the secretion of mucosal antibodies in oral fluid. Here, a systematic analysis was performed of serological and mucosal antibody secretion against 6 ASFV antigens after direct or indirect infection with four different ASFV strains or genotypes, namely, the field virulent genotype II isolate ASFV HLJ/18, the artificially attenuated genotype II strain HLJ/18-7GD, the naturally attenuated genotype II isolate HLJ/HRB1/20, and genotype I isolate SD/DY-I/21. Severe clinical signs of HLJ/18 infection were observed in pigs from 4 days postinoculation. However, no clinical signs were observed in HLJ/18-7GD-infected pigs. The contact pigs cohoused with the pigs intramuscularly infected with the isolate SD/DY-I/21 or HLJ/HRB1/20 only showed chronic clinical signs. Interestingly, the oral fluid sIgA responses to all the selected antigens were significantly stronger and earlier than the serum IgG responses in both HLJ/18- and HLJ/18-7GD-challenged pigs. Although significant fluctuations and individual differences appeared in oral swab sIgA responses in the contact transmission group, they were earlier than the corresponding serological IgG responses. Moreover, according to the comparative analysis of the three infection groups, P54 was proposed to be a dominant target for serological IgG diagnosis, while P30, CD2v, P54, P22, and P10 were more advantageous as mucosal sIgA diagnosis targets. These results highlight the important role of mucosal antibodies in the early diagnosis of ASFV infection and can provide references to screen appropriate targets for ASFV detection. |
doi_str_mv | 10.1155/2023/9959847 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2802485283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2802485283</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-41367a6a5ec4d83789eba8fdad0308b91f5294aefb6e6484a1531f1de851667a3</originalsourceid><addsrcrecordid>eNp90M9PwjAUB_DFaCKiN_-AJh510q5r1x0JgpJgNKJel257xZLRznYT51_vCMSjp_cOn_cj3yC4JPiWEMZGEY7oKE1ZKuLkKBgQwVlIuIiO__okPg3OvF9jzHHK2SD4ueuM3OjCI6vQEpyt7EoXskLSlOixLazv-7FpdG7LDr2Ar63x4JFcSW18g8bK9dyg5VYbQDP4AofetWt3Rhs0_a7B6Q2YRlZVh-ZGQdFAiZ71yp8HJ0pWHi4OdRi8zaavk4dw8XQ_n4wXYUFp0oQxoTyRXDIo4lLQRKSQS6FKWWKKRZ4SxaI0lqByDjwWsSSMEkVKEIzwfpIOg6v93trZzxZ8k61t60x_MosEjmLBIkF7dbNXhbPeO1BZ3T8uXZcRnO3SzXbpZod0e3695x_alHKr_9e_U1d61w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2802485283</pqid></control><display><type>article</type><title>Dynamics of Serological and Mucosal Antibody Responses against African Swine Fever Viruses in Experimentally Infected Pigs</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><creator>Xie, Qingyun ; Bai, Yun ; Wang, Wan ; Chen, Rong ; Xing, Huixuan ; Wu, Yuzi ; Shao, Guoqing ; Bu, Zhigao ; Zhao, Dongming ; Feng, Zhixin</creator><contributor>Khurshid, Mohsin ; Mohsin Khurshid</contributor><creatorcontrib>Xie, Qingyun ; Bai, Yun ; Wang, Wan ; Chen, Rong ; Xing, Huixuan ; Wu, Yuzi ; Shao, Guoqing ; Bu, Zhigao ; Zhao, Dongming ; Feng, Zhixin ; Khurshid, Mohsin ; Mohsin Khurshid</creatorcontrib><description>African swine fever virus (ASFV) is a lethal swine pathogen, and there is no effective vaccine or treatment available for ASFV infection. Recently, the occurrence of ASFV genotype I and genotype II natural mutants that manifest as subacute, longer-incubation, or persistent infections poses threats to preventing ASFV infection. The dynamics of antibody responses to ASFV are still completely unrevealed, especially the secretion of mucosal antibodies in oral fluid. Here, a systematic analysis was performed of serological and mucosal antibody secretion against 6 ASFV antigens after direct or indirect infection with four different ASFV strains or genotypes, namely, the field virulent genotype II isolate ASFV HLJ/18, the artificially attenuated genotype II strain HLJ/18-7GD, the naturally attenuated genotype II isolate HLJ/HRB1/20, and genotype I isolate SD/DY-I/21. Severe clinical signs of HLJ/18 infection were observed in pigs from 4 days postinoculation. However, no clinical signs were observed in HLJ/18-7GD-infected pigs. The contact pigs cohoused with the pigs intramuscularly infected with the isolate SD/DY-I/21 or HLJ/HRB1/20 only showed chronic clinical signs. Interestingly, the oral fluid sIgA responses to all the selected antigens were significantly stronger and earlier than the serum IgG responses in both HLJ/18- and HLJ/18-7GD-challenged pigs. Although significant fluctuations and individual differences appeared in oral swab sIgA responses in the contact transmission group, they were earlier than the corresponding serological IgG responses. Moreover, according to the comparative analysis of the three infection groups, P54 was proposed to be a dominant target for serological IgG diagnosis, while P30, CD2v, P54, P22, and P10 were more advantageous as mucosal sIgA diagnosis targets. These results highlight the important role of mucosal antibodies in the early diagnosis of ASFV infection and can provide references to screen appropriate targets for ASFV detection.</description><identifier>ISSN: 1865-1674</identifier><identifier>EISSN: 1865-1682</identifier><identifier>DOI: 10.1155/2023/9959847</identifier><language>eng</language><publisher>Berlin: Hindawi</publisher><subject>African swine fever ; Antibodies ; Antigens ; Comparative analysis ; Diagnosis ; Fever ; Genomes ; Genotype & phenotype ; Genotypes ; Hogs ; Immunoglobulin G ; Infections ; Laboratory animals ; Medical research ; Mucosa ; Proteins ; Secretion ; Serology ; Swine ; Target detection ; Virulence ; Viruses</subject><ispartof>Transboundary and emerging diseases, 2023-02, Vol.2023, p.1-12</ispartof><rights>Copyright © 2023 Qingyun Xie et al.</rights><rights>Copyright © 2023 Qingyun Xie et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-41367a6a5ec4d83789eba8fdad0308b91f5294aefb6e6484a1531f1de851667a3</citedby><cites>FETCH-LOGICAL-c337t-41367a6a5ec4d83789eba8fdad0308b91f5294aefb6e6484a1531f1de851667a3</cites><orcidid>0000-0002-5451-1055 ; 0000-0001-7161-6214 ; 0000-0002-0346-9248 ; 0000-0001-9113-4706 ; 0000-0002-2852-7221 ; 0000-0002-6669-6587 ; 0000-0002-7785-8553 ; 0000-0002-2033-8565 ; 0000-0001-9783-7349 ; 0000-0001-9242-4211</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2802485283/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2802485283?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25744,27915,27916,37003,44581,74887</link.rule.ids></links><search><contributor>Khurshid, Mohsin</contributor><contributor>Mohsin Khurshid</contributor><creatorcontrib>Xie, Qingyun</creatorcontrib><creatorcontrib>Bai, Yun</creatorcontrib><creatorcontrib>Wang, Wan</creatorcontrib><creatorcontrib>Chen, Rong</creatorcontrib><creatorcontrib>Xing, Huixuan</creatorcontrib><creatorcontrib>Wu, Yuzi</creatorcontrib><creatorcontrib>Shao, Guoqing</creatorcontrib><creatorcontrib>Bu, Zhigao</creatorcontrib><creatorcontrib>Zhao, Dongming</creatorcontrib><creatorcontrib>Feng, Zhixin</creatorcontrib><title>Dynamics of Serological and Mucosal Antibody Responses against African Swine Fever Viruses in Experimentally Infected Pigs</title><title>Transboundary and emerging diseases</title><description>African swine fever virus (ASFV) is a lethal swine pathogen, and there is no effective vaccine or treatment available for ASFV infection. Recently, the occurrence of ASFV genotype I and genotype II natural mutants that manifest as subacute, longer-incubation, or persistent infections poses threats to preventing ASFV infection. The dynamics of antibody responses to ASFV are still completely unrevealed, especially the secretion of mucosal antibodies in oral fluid. Here, a systematic analysis was performed of serological and mucosal antibody secretion against 6 ASFV antigens after direct or indirect infection with four different ASFV strains or genotypes, namely, the field virulent genotype II isolate ASFV HLJ/18, the artificially attenuated genotype II strain HLJ/18-7GD, the naturally attenuated genotype II isolate HLJ/HRB1/20, and genotype I isolate SD/DY-I/21. Severe clinical signs of HLJ/18 infection were observed in pigs from 4 days postinoculation. However, no clinical signs were observed in HLJ/18-7GD-infected pigs. The contact pigs cohoused with the pigs intramuscularly infected with the isolate SD/DY-I/21 or HLJ/HRB1/20 only showed chronic clinical signs. Interestingly, the oral fluid sIgA responses to all the selected antigens were significantly stronger and earlier than the serum IgG responses in both HLJ/18- and HLJ/18-7GD-challenged pigs. Although significant fluctuations and individual differences appeared in oral swab sIgA responses in the contact transmission group, they were earlier than the corresponding serological IgG responses. Moreover, according to the comparative analysis of the three infection groups, P54 was proposed to be a dominant target for serological IgG diagnosis, while P30, CD2v, P54, P22, and P10 were more advantageous as mucosal sIgA diagnosis targets. These results highlight the important role of mucosal antibodies in the early diagnosis of ASFV infection and can provide references to screen appropriate targets for ASFV detection.</description><subject>African swine fever</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Comparative analysis</subject><subject>Diagnosis</subject><subject>Fever</subject><subject>Genomes</subject><subject>Genotype & phenotype</subject><subject>Genotypes</subject><subject>Hogs</subject><subject>Immunoglobulin G</subject><subject>Infections</subject><subject>Laboratory animals</subject><subject>Medical research</subject><subject>Mucosa</subject><subject>Proteins</subject><subject>Secretion</subject><subject>Serology</subject><subject>Swine</subject><subject>Target detection</subject><subject>Virulence</subject><subject>Viruses</subject><issn>1865-1674</issn><issn>1865-1682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp90M9PwjAUB_DFaCKiN_-AJh510q5r1x0JgpJgNKJel257xZLRznYT51_vCMSjp_cOn_cj3yC4JPiWEMZGEY7oKE1ZKuLkKBgQwVlIuIiO__okPg3OvF9jzHHK2SD4ueuM3OjCI6vQEpyt7EoXskLSlOixLazv-7FpdG7LDr2Ar63x4JFcSW18g8bK9dyg5VYbQDP4AofetWt3Rhs0_a7B6Q2YRlZVh-ZGQdFAiZ71yp8HJ0pWHi4OdRi8zaavk4dw8XQ_n4wXYUFp0oQxoTyRXDIo4lLQRKSQS6FKWWKKRZ4SxaI0lqByDjwWsSSMEkVKEIzwfpIOg6v93trZzxZ8k61t60x_MosEjmLBIkF7dbNXhbPeO1BZ3T8uXZcRnO3SzXbpZod0e3695x_alHKr_9e_U1d61w</recordid><startdate>20230225</startdate><enddate>20230225</enddate><creator>Xie, Qingyun</creator><creator>Bai, Yun</creator><creator>Wang, Wan</creator><creator>Chen, Rong</creator><creator>Xing, Huixuan</creator><creator>Wu, Yuzi</creator><creator>Shao, Guoqing</creator><creator>Bu, Zhigao</creator><creator>Zhao, Dongming</creator><creator>Feng, Zhixin</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7U9</scope><scope>7X2</scope><scope>7XB</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M0K</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0002-5451-1055</orcidid><orcidid>https://orcid.org/0000-0001-7161-6214</orcidid><orcidid>https://orcid.org/0000-0002-0346-9248</orcidid><orcidid>https://orcid.org/0000-0001-9113-4706</orcidid><orcidid>https://orcid.org/0000-0002-2852-7221</orcidid><orcidid>https://orcid.org/0000-0002-6669-6587</orcidid><orcidid>https://orcid.org/0000-0002-7785-8553</orcidid><orcidid>https://orcid.org/0000-0002-2033-8565</orcidid><orcidid>https://orcid.org/0000-0001-9783-7349</orcidid><orcidid>https://orcid.org/0000-0001-9242-4211</orcidid></search><sort><creationdate>20230225</creationdate><title>Dynamics of Serological and Mucosal Antibody Responses against African Swine Fever Viruses in Experimentally Infected Pigs</title><author>Xie, Qingyun ; Bai, Yun ; Wang, Wan ; Chen, Rong ; Xing, Huixuan ; Wu, Yuzi ; Shao, Guoqing ; Bu, Zhigao ; Zhao, Dongming ; Feng, Zhixin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-41367a6a5ec4d83789eba8fdad0308b91f5294aefb6e6484a1531f1de851667a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>African swine fever</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Comparative analysis</topic><topic>Diagnosis</topic><topic>Fever</topic><topic>Genomes</topic><topic>Genotype & phenotype</topic><topic>Genotypes</topic><topic>Hogs</topic><topic>Immunoglobulin G</topic><topic>Infections</topic><topic>Laboratory animals</topic><topic>Medical research</topic><topic>Mucosa</topic><topic>Proteins</topic><topic>Secretion</topic><topic>Serology</topic><topic>Swine</topic><topic>Target detection</topic><topic>Virulence</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xie, Qingyun</creatorcontrib><creatorcontrib>Bai, Yun</creatorcontrib><creatorcontrib>Wang, Wan</creatorcontrib><creatorcontrib>Chen, Rong</creatorcontrib><creatorcontrib>Xing, Huixuan</creatorcontrib><creatorcontrib>Wu, Yuzi</creatorcontrib><creatorcontrib>Shao, Guoqing</creatorcontrib><creatorcontrib>Bu, Zhigao</creatorcontrib><creatorcontrib>Zhao, Dongming</creatorcontrib><creatorcontrib>Feng, Zhixin</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Transboundary and emerging diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xie, Qingyun</au><au>Bai, Yun</au><au>Wang, Wan</au><au>Chen, Rong</au><au>Xing, Huixuan</au><au>Wu, Yuzi</au><au>Shao, Guoqing</au><au>Bu, Zhigao</au><au>Zhao, Dongming</au><au>Feng, Zhixin</au><au>Khurshid, Mohsin</au><au>Mohsin Khurshid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dynamics of Serological and Mucosal Antibody Responses against African Swine Fever Viruses in Experimentally Infected Pigs</atitle><jtitle>Transboundary and emerging diseases</jtitle><date>2023-02-25</date><risdate>2023</risdate><volume>2023</volume><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>1865-1674</issn><eissn>1865-1682</eissn><abstract>African swine fever virus (ASFV) is a lethal swine pathogen, and there is no effective vaccine or treatment available for ASFV infection. Recently, the occurrence of ASFV genotype I and genotype II natural mutants that manifest as subacute, longer-incubation, or persistent infections poses threats to preventing ASFV infection. The dynamics of antibody responses to ASFV are still completely unrevealed, especially the secretion of mucosal antibodies in oral fluid. Here, a systematic analysis was performed of serological and mucosal antibody secretion against 6 ASFV antigens after direct or indirect infection with four different ASFV strains or genotypes, namely, the field virulent genotype II isolate ASFV HLJ/18, the artificially attenuated genotype II strain HLJ/18-7GD, the naturally attenuated genotype II isolate HLJ/HRB1/20, and genotype I isolate SD/DY-I/21. Severe clinical signs of HLJ/18 infection were observed in pigs from 4 days postinoculation. However, no clinical signs were observed in HLJ/18-7GD-infected pigs. The contact pigs cohoused with the pigs intramuscularly infected with the isolate SD/DY-I/21 or HLJ/HRB1/20 only showed chronic clinical signs. Interestingly, the oral fluid sIgA responses to all the selected antigens were significantly stronger and earlier than the serum IgG responses in both HLJ/18- and HLJ/18-7GD-challenged pigs. Although significant fluctuations and individual differences appeared in oral swab sIgA responses in the contact transmission group, they were earlier than the corresponding serological IgG responses. Moreover, according to the comparative analysis of the three infection groups, P54 was proposed to be a dominant target for serological IgG diagnosis, while P30, CD2v, P54, P22, and P10 were more advantageous as mucosal sIgA diagnosis targets. These results highlight the important role of mucosal antibodies in the early diagnosis of ASFV infection and can provide references to screen appropriate targets for ASFV detection.</abstract><cop>Berlin</cop><pub>Hindawi</pub><doi>10.1155/2023/9959847</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-5451-1055</orcidid><orcidid>https://orcid.org/0000-0001-7161-6214</orcidid><orcidid>https://orcid.org/0000-0002-0346-9248</orcidid><orcidid>https://orcid.org/0000-0001-9113-4706</orcidid><orcidid>https://orcid.org/0000-0002-2852-7221</orcidid><orcidid>https://orcid.org/0000-0002-6669-6587</orcidid><orcidid>https://orcid.org/0000-0002-7785-8553</orcidid><orcidid>https://orcid.org/0000-0002-2033-8565</orcidid><orcidid>https://orcid.org/0000-0001-9783-7349</orcidid><orcidid>https://orcid.org/0000-0001-9242-4211</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1865-1674 |
ispartof | Transboundary and emerging diseases, 2023-02, Vol.2023, p.1-12 |
issn | 1865-1674 1865-1682 |
language | eng |
recordid | cdi_proquest_journals_2802485283 |
source | Wiley Online Library Open Access; Publicly Available Content Database |
subjects | African swine fever Antibodies Antigens Comparative analysis Diagnosis Fever Genomes Genotype & phenotype Genotypes Hogs Immunoglobulin G Infections Laboratory animals Medical research Mucosa Proteins Secretion Serology Swine Target detection Virulence Viruses |
title | Dynamics of Serological and Mucosal Antibody Responses against African Swine Fever Viruses in Experimentally Infected Pigs |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T06%3A05%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dynamics%20of%20Serological%20and%20Mucosal%20Antibody%20Responses%20against%20African%20Swine%20Fever%20Viruses%20in%20Experimentally%20Infected%20Pigs&rft.jtitle=Transboundary%20and%20emerging%20diseases&rft.au=Xie,%20Qingyun&rft.date=2023-02-25&rft.volume=2023&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=1865-1674&rft.eissn=1865-1682&rft_id=info:doi/10.1155/2023/9959847&rft_dat=%3Cproquest_cross%3E2802485283%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c337t-41367a6a5ec4d83789eba8fdad0308b91f5294aefb6e6484a1531f1de851667a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2802485283&rft_id=info:pmid/&rfr_iscdi=true |